Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06295809
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-02-29
Brief Title:
A Study of NeoAdjuvant V940 and Pembrolizumab in Cutaneous Squamous Cell Carcinoma V940-007
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-18
Start Date Type:
ACTUAL
Primary Completion Date:
2029-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2033-05-06
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-29
First Submit QC Date:
February 29 2024
Study First Post Date:
2024-03-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-17
Last Update Post Date:
2024-07-12
Last Update Post Date Type:
ACTUAL